Epigenetic regulation of latent Epstein-Barr virus promoters

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 3-4, 2010, Pages 228-235

  Takacs, Maria ^a   Banati, Ferenc ^a   Koroknai, Anita ^a   Segesdi, Judit ^a   Salamon, Daniel ^a   Wolf, Hans ^b   Niller, Hans Helmut ^b   Minarovits, Janos ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CTCF; DNA methylation; Epstein Barr virus; histone modifications; locus control region; matrix attachment region; transcription factory

Indexed keywords

BETA GLOBULIN; CELL SURFACE MARKER; DINUCLEOTIDE; EPSTEIN BARR VIRUS ANTIGEN 2; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE INHIBITOR; HISTONE METHYLTRANSFERASE; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; NUCLEAR FACTOR Y; NUCLEASE; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A; VIRUS DNA;

B LYMPHOBLAST; BURKITT LYMPHOMA; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL NUCLEUS MATRIX; CHROMATIN; DNA BINDING; DNA FLANKING REGION; DNA FOOTPRINTING; DNA METHYLATION; DNA REPLICATION; DNA SEQUENCE; DNA SYNTHESIS; EPIGENETICS; EPISOME; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; HETEROCHROMATIN; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN GENE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MATRIX ATTACHMENT REGION; MEMORY CELL; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOSOME; ONCOGENE MYC; PATHOGENESIS; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REED STERNBERG CELL; REVIEW; STOMACH CARCINOMA; VIRUS GENE; VIRUS INFECTION;

ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PROMOTER REGIONS, GENETIC; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 77949333092     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2009.10.005     Document Type: Review

References (83)

1. Niller H.H., Wolf H., and Minarovits J. Epstein-Barr virus. In: Minarovits J., Gonczol E., and Valyi-Nagy T. (Eds). Latency Strategies of Herpesviruses (2007), Springer 154-191
2. Shannon-Lowe C.D., Neuhierl B., Baldwin G., Rickinson A.B., and Delecluse H. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7065-7070
3. Li H., and Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 89 (2003) 133-156
4. Fixman E.D., Hayward G.S., and Hayward D. Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. Virology 66 (1992) 5029-5030
5. Sato H., Takimoto T., Tanaka S., Tanaka J., and Raab-Traub N. Concatemeric replication of Epstein-Barr virus: structure of termini in virus producer and newly transformed cell lines. J. Virol. 64 (1990) 5295-5300
6. Hammerschmidt W., and Sugden B. Identification and characterization of orilyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55 (1988) 427-433
7. Raab-Traub N., and Flynn K. The structure of the termini of the Epstein-Barr virus is a marker of clonal cell proliferation. Cell 47 (1986) 883-889
8. Miller G. Epstein-Barr virus: biology, pathogenesis and medical aspects. In: Fields B.N., and Knipe D.M. (Eds). Virology (1990), Raven Press, New York 1921-1958
9. Smith P. Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. Semin. Cancer Biol. 11 (2001) 469-476
10. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., Raab-Traub N., and Cullen B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2 (2006) e23
11. Niller H.H., Salamon D., Banati F., Schwarzmann F., Wolf H., and Minarovits J. The LCR of EBV makes Burkitt's lymphoma endemic. Trends Microbiol. 12 (2004) 495-499
12. Dyson P., and Farrell P.J. Chromatin structure of Epstein-Barr virus. J. Gen. Virol. 66 (1985) 1931-1940
13. Verdone L., Caserta M., and Di Mauro E. Role of histone acetylation in the control of gene expression. Biochem. Cell Biol. 83 (2005) 344-353
14. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
15. Alazard N., Gruffat H., Hiriart E., Sergeant A., and Manet E. Differential hyperacetylation of Histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. J. Virol. 77 (2003) 8166-8172
16. Chau C.M., and Lieberman P.M. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J. Virol. 78 (2004) 12308-12319
17. Day L., Chau C.M., Nebozhyn M., Rennekamp A.J., Showe M., and Lieberman P.M. Chromatin profiling of Epstein-Barr virus latency control region. J. Virol. 81 (2007) 6389-6401
18. Fejer G., Koroknai A., Banati F., Györy I., Salamon D., Wolf H., Niller H.H., and Minarovits J. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J. Gen. Virol. 89 (2008) 1364-1370
19. Gerle B., Koroknai A., Fejer G., Bakos A., Banati F., Szenthe K., Wolf H., Niller H.H., Minarovits J., and Salamon D. Acetylated histone H3 and H4 mark the upregulated LMP2A-promoter of Epstein-Barr virus in lymphoid cells. J. Virol. 81 (2007) 13242-13247
20. Salamon D., Takacs M., Ujvari D., Uhlig J., Minarovits J., and Niller H.H. Protein-DNA-binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp and LMP1p of Epstein-Barr virus. J. Virol. 75 (2001) 2584-2596
21. Schneider R., Bannister A.J., Myers F.A., Thorne A.W., Crane-Robinson C., and Kozuarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6 (2004) 73-77
22. Roh T.Y., Cuddapah S., and Zhao K. Active chromatin domains are defined by acetylation islands defined by genome-wide mapping. Genes Dev. 19 (2005) 542-552
23. Altiok E., Minarovits J., Hu L.F., Contreras-Brodin B., Klein G., and Ernberg I. Host-cell-phenotype dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 905-909
24. Robertson K.D., Manns A., Swinnen L.J., Zong J.C., Gulley M.L., and Ambinder R. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacítidine treatment: evidence that demethylation at a single CpG site is crucial. Mol. Cell. Biol. 15 (1995) 6150-6159
25. Takacs M., Myöhänen S., Altiok E., and Minarovits J. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing. Biol. Chem. 379 (1998) 417-422
26. Jones P., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., and Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19 (1998) 187-191
27. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., and Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
28. Ng H.H., Jeppesen P., and Bird A. Active repression of methylated genes by the chromosomal protein MBD1. Mol. Cell. Biol. 20 (2000) 1394-1406
29. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., and Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet 24 (2000) 88-91
30. Lachner M., and Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14 (2002) 286-298
31. Gyo{double acute}ry I., and Minarovits J. Epigenetic regulation of lymphoid specific gene sets. Biochem. Cell Biol. 83 (2005) 286-295
32. Ling P.D., Hsieh J.D., Ruf I.K., Rawlins D.E., and Hayward S.D. EBNA-2 upregulation of Epstein-Barr virus promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68 (1994) 5375-5383
33. Hsieh J.J.D., Nofziger D., Weinmaster G., and Hayward D. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation. J. Virol. 71 (1997) 1938-1945
34. Höfelmayr H., Strobl L.J., Marschall G., Bornkamm G.W., and Zimmer-Strobl U. Activated Notch 1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J. Virol. 75 (2001) 2033-2040
35. Hsieh J.J.D., and Hayward S.D. Masking the CBF1/RBPJκ transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268 (1995) 560-563
36. Salamon D., Takacs M., Schwarzmann F., Wolf H., Minarovits J., and Niller H.H. High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27 (2003) 57-66
37. Tao Q., Robertson K.D., Manns A., Hildesheim A., and Ambinder R.F. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J. Virol. 72 (1998) 7075-7083
38. Yates J.L., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 3806-3810
39. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
40. Falk K., and Ernberg I. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5 kb unmethylated region. Virology 195 (1993) 608-615
41. Falk K., Szekely L., Aleman A., and Ernberg I. Specific methylation patterns of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J. Virol. 72 (1998) 2969-2974
42. Salamon D., Takacs M., Myöhänen S., Marcsek Z., Berencsi G., and Minarovits J. De novo methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes. Biol. Chem. 381 (2000) 95-105
43. Wensing B., Stühler A., Jenkins P., Hollyoake M., Karstegl C.E., and Farrell P.J. Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER expression by upstream sequences and oriP. J. Virol. 75 (2001) 6235-6241
44. Jankelevich S., Kolman J., Bodnar J.W., and Miller G. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J. 11 (1992) 1165-1176
45. Rawlins D.R., Milman G., Hayward S.D., and Hayward G.S. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen to clustered int he plasmid maintenance region. Cell 42 (1985) 859-868
46. Zhou J., Chau C., Deng Z., Stedman W., and Lieberman P.M. Epigenetic control of replication origins. Cell Cycle 4 (2005) 889-892
47. Zhou J., Snyder A.R., and Lieberman P.M. Epstein-Barr virus episome stability is coupled to a delay in replication timing. J. Virol. 83 (2008) 2154-2162
48. Sugden B., and Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63 (1989) 2644-2649
49. Gahn T.A., and Sugden B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69 (1995) 2633-2636
50. Puglielli M.T., and Woisetschlaeger M. S.H. Speck, oriP is essential for EBNA gene promoter activity in Epstein-Barr virus immortalized lymphoblastoid cell lines. J. Virol. 70 (1996) 5758-5768
51. Contreras-Brodin B.A., Anvret N., Imreh S., Altiok E., Klein G., and Masucci M.G. B cell phenotype-dependent expression of Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. J. Gen. Virol. 72 (1991) 3025-3033
52. Sung N.S., Kenney S., Gutsch D., and Pagano D. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI-C promoter of Epstein-Barr virus. J. Virol. 65 (1991) 2644-2649
53. Jin X.W., and Speck S.H. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J. Virol. 66 (1992) 2846-2852
54. Filippova G.N. Genetics and epigenetics of the multifunctional protein CTCF. Curr. Top. Dev. Biol. 80 (2008) 337-360
55. Wallace J.A., and Felsenfeld G. We gather together: insulators and genome organization. Curr. Opin. Genet. Dev. 17 (2007) 400-407
56. Chau C.M., Zhang X.Y., McMahon S.B., and Lieberman P.M. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J. Virol. 80 (2006) 5723-5732
57. Kirchmaier A., and Sugden B. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol. 72 (1998) 4657-4666
58. Salamon D., Banati F., Koroknai A., Ravasz M., Szenthe K., Bathori Z., Bakos A., Niller H.H., Wolf H., and Minarovits J. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. J. Gen. Virol. 90 (2009) 1183-1189
59. Dunn K.L., Zhao H., and Davie J.R. The insulator binding protein CTCF associates with the nuclear matrix. Exp. Cell Res. 288 (2003) 218-223
60. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16 (2002) 6-21
61. Levine S.S., King I.F., and Kingston R.E. Division of labor in Polycomb group repression. Trends Biochem. Sci. 29 (2004) 479-485
62. Cernilogar F.M., and Orlando V. Epigenome programming by Polycomb and Trithorax proteins. Biochem. Cell Biol. 83 (2005) 322-331
63. Dutton A., Woodman C.B., Chukwuma M.B., Wei W., Vockerodt M., Baumforth K.R., Flavell J.R., Taylor A.M., Young L.S., and Murray P.G. Bmi-1 is induced by the Epstein-Barr virus viral oncogene LMP-1 and regulates the expression of target genes in Hodgkin lymphoma cells. Blood 109 (2007) 2597-2603
64. Li Q., Peterson K.R., Fang X., and Stamatoyannopoulos G. Locus control regions. Blood 100 (2002) 3077-3086
65. Niller H.H., Salamon D., Ilg K., Koroknai A., Banati F., Bäuml G., Rücker O.L., Schwarzmann F., Wolf H., and Minarovits J. The in vivo binding site for oncoprotein c.Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med. Sci. Monitor 9 (2003) 1-9
66. Banati F., Koroknai A., Salamon D., Takacs M., Minarovits-Kormuta S., Wolf H., Niller H.H., and Minarovits J. CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus. FEBS Lett. 582 (2008) 705-709
67. Niller H.H., Glaser G., Knüchel R., and Wolf H. Nucleoprotein complexes and DNA 5′-ends at oriP of Epstein-Barr virus. J. Biol. Chem. 270 (1995) 12864-12868
68. Van Straaten J.P., and Rabbits T.H. The c-myc protein is associated with the nuclear matrix through specific metal interaction. Oncogene Res. 1 (1987) 221-228
69. Amati B., Frank S.R., Donjerkovic D., and Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta 1471 (2001) M135-M145
70. Bartlett J., Blagojevic J., Carter D., Eskiw C., Fromaget M., Job C., Shamster M., Trindade I.F., Xu M., and Cook P.R. Specialized transcription factories. Biochem. Soc. Symp. 73 (2006) 67-75
71. Xu M., and Cook P.R. Similar active genes cluster in specialized transcription factories. J. Cell Biol. 181 (2008) 615-623
72. Boreström C., Zetterberg H., Liff K., and Rymo L. Functional interaction of nuclear factor Y and Sp1 is required for activation of the Epstein-Barr virus C promoter. J. Virol. 77 (2003) 821-829
73. Woisetschlaeger M., Strominger J.I., and Speck S.H. Mutually exclusive usage of viral promoters in Epstein-Barr virus infected lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6498-6509
74. Hutchings I.A., Tierney R.J., Kelly G.L., Stylianou J., Rickinson A.G., and Bell A.I. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J. Virol. 80 (2006) 10700-10711
75. Johannsen E., Koh E., Mosialos G., Tong X., Kieff E., and Grossman S.R. Epstein-Barr virus nuclear protein transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69 (1995) 253-262
76. Wang L., Grossman S.R., and Kieff E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 430-435
77. Sjöblom-Hallén A., Yang W., Jansson A., and Rymo L. Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure. J. Virol. 73 (1999) 2983-2993
78. Sadler R.H., and Raab-Traub N. The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J. Virol. 69 (1995) 4577-4581
79. Salamon D., Takacs M., Schwarzmann F., Wolf H., Minarovits J., and Niller H.H. High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27 (2003) 66-67
80. Zhang J., Chen H., Weinmaster G., and Hayward S.D. Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIP to negatively regulate the activity of EBNA2 and NotchIC. J. Virol. 75 (2001) 2946-2956
81. de Jesus O., Smith P.R., Spender L., Elgueta K.C., Niller H.H., Huang D., and Farrell P.J. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAS of EBV. J. Gen. Virol. 84 (2003) 1443-1450
82. Minarovits J., Hu L.F., Marcsek Z., Minarovits-Kormuta S., Klein G., and Ernberg I. RNA polymerase III-transcribed EBER1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. J. Gen. Virol. 73 (1992) 1687-1692
83. Minarovits J. Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. Acta Microbiol. Immunol. Hung. 56 (2009) 1-19